Triflubazam

From WikiMD's Food, Medicine & Wellness Encyclopedia

Triflubazam is a benzodiazepine derivative. It has anxiolytic properties and was developed by Hoffmann-La Roche in the 1960s.

Chemistry[edit | edit source]

Triflubazam is a 1,5-benzodiazepine, with the nitrogen atoms located at positions 1 and 5 of the diazepine ring; therefore, it is more accurately referred to as a 1,5-benzodiazepine.

Pharmacology[edit | edit source]

Triflubazam has anxiolytic properties which are approximately equivalent to those of diazepam. However, it has a somewhat slower onset of action than diazepam, and is less sedating.

History[edit | edit source]

Triflubazam was developed by Hoffmann-La Roche in the 1960s, but was never marketed.

See also[edit | edit source]

Triflubazam Resources
Doctor showing form.jpg

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski


References[edit | edit source]


External links[edit | edit source]


Benzodiazipines[edit source]

Template:Hoffmann-La Roche products

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD